Philip Philip
MD, PhD
Professor of Oncology, Leader GI Oncology Multidisciplinary Team
👥Biography 个人简介
Philip Philip co-chaired the SWOG S1505 trial comparing perioperative mFOLFIRINOX versus gemcitabine plus nab-paclitaxel in resectable pancreatic cancer. He leads GI oncology at Henry Ford Cancer Institute and the SWOG GI committee. His work has shaped the adoption of neoadjuvant strategies in pancreatic adenocarcinoma.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Philip Philip 的研究动态
Follow Philip Philip's research updates
留下邮箱，当我们发布与 Philip Philip（Henry Ford Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment